Categories

Epiomic Epidemiology Series: Stomach Cancer Forecast in 17 Major Markets 2016-2026

US$ 6100

“Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Stomach Cancer in 17 Major Markets
Stomach cancer is a broad term encompassing tumours arising in the stomach and includes gastric carcinoma which is a malignant epithelial-origin tumour commonly developing after prolonged periods of gastritis. Stomach cancers tend to develop slowly over many years spreading in different ways.

03-21 2016   Pages: 66

Epiomic Epidemiology Series: Familial Dyslipidaemia Forecast in 8 Major Markets 2016-2026

US$ 6100

“Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Dyslipidaemia (Familial Type) in 8 Major Markets
Dyslipidaemia is defined as individuals with elevated triglycerides, low density lipoprotein or total cholesterol, or with lowered levels of high density lipoprotein. Many patients meet the requirements of Dyslipidaemia on more than one factor.

03-21 2016   Pages: 40

Epiomic Epidemiology Series: Systemic Lupus Erythematosus Forecast in 8 Major Markets 2016-2026

US$ 6100

“Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Systemic Lupus Erythematosus in 8 Major Markets
Systemic Lupus Erythematosus (SLE) is an autoimmune disease, characterised by an autoantibody response to nuclear and cytoplasmic antigens. It is a systemic disease, with a large spectrum of signs and symptoms.

03-07 2016   Pages: 48

Epiomic Epidemiology Series: Peripheral Arterial Disease Forecast in 20 Major Markets 2016-2026

US$ 6100

“Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Peripheral Arterial Disease (PAD) in 20 Major Markets
Peripheral Arterial disease (PAD) is an occlusion of the peripheral arteries and is widely viewed as a measure of an individual’s global systemic atherosclerotic burden.

03-07 2016   Pages: 80

Epiomic Epidemiology Series: Ulcerative Colitis Forecast in 8 Major Markets 2016-2026

US$ 6100

“Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Ulcerative Colitis in 8 Major Markets
Ulcerative Colitis (UC) is an inflammatory bowel disease (IBD) causing chronic inflammation in the colon, and is treated as an autoimmune disease. While sharing some features with Crohn’s disease, UC is an intermittent disease with periods of symptoms interspersed with asymptomatic periods (generally induced by response to treatment).

03-07 2016   Pages: 42

Epiomic Epidemiology Series: Pancreatic Cancer Forecast in 17 Major Markets 2016-2026

US$ 6100

“Black Swan Analysis Epiomic™ Epidemiology Forecast Report on Pancreatic Cancer in 17 Major Markets
Pancreatic cancer is one of the most deadly cancers in the world. Pancreatic cancer is a result of malignant cells forming in the tissue of the pancreas, and typically spreads rapidly with detection usually in the later stages of the disease.

03-07 2016   Pages: 54

Epiomic Epidemiology Series: Restless Leg Syndrome Forecast in 13 Major Markets 2016-2026

US$ 6100

“Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Restless Legs Syndrome in 13 Major Markets
Restless Legs Syndrome (RLS), also known as Willis-Ekbom Disorder, is a sensimotor sleep disorder. Clinically, RLS is characterized by disagreeable leg sensations occurring most often at sleep onset that provoke an irresistible urge to move legs.

03-07 2016   Pages: 52

Epiomic Epidemiology Series: Frontotemporal Lobe Dementia Forecast in 9 Major Markets 2015-2025

US$ 6100

Frontotemporal lobe dementia (FTD) is a progressive degenerative disorder characterised by degeneration and atrophy of the frontal and anterior temporal lobes. It is the second most common neurodegenerative disorder resulting in dementia in the under 65’s and a limited life expectancy.

12-15 2015   Pages: 38

Epiomic Epidemiology Series: Idiopathic Pulmonary Fibrosis Forecast in 9 Major Markets 2015-2025

US$ 6100

Idiopathic pulmonary fibrosis (IPF) is defined as a specific form of chronic, progressive, fibrosing interstitial pneumonia of unknown cause. The disease is idiopathic, although a number of possible causes have been identified,

12-15 2015   Pages: 38

Gaucher’s Disease Epiomic Insights, 2015-2020

US$ 1050

Epiomic™ Insights for Gaucher’s disease provides you with a top line snapshot of the market potential in terms of patient populations for this rare disease. With a low awareness of the condition in the clinical community and low diagnostic rates, there is a challenge in obtaining accurate patient population data.

12-01 2015   Pages: 1
Contact With Us
Join templatemonster at google+
Customized Research
Request Sample